Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Prophylactic Human Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prophylactic Human Vaccinemarket, defines the market attractiveness level of Prophylactic Human Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prophylactic Human Vaccine industry, describes the types of Prophylactic Human Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prophylactic Human Vaccine market and the development prospects and opportunities of Prophylactic Human Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prophylactic Human Vaccine market in Chapter 13.
By Player:
Zoetis
GSK
Merck
McKesson Medical
Biovac
Sanofi
Merial
By Type:
Inactivated Vaccine
Attenuated Vaccine
Others
By End-User:
Hospital
Scientific Research
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prophylactic Human Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prophylactic Human Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prophylactic Human Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prophylactic Human Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prophylactic Human Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Prophylactic Human Vaccine Consumption (2017-2022)
-
7.2 United States Prophylactic Human Vaccine Consumption (2017-2022)
-
7.3 Europe Prophylactic Human Vaccine Consumption (2017-2022)
-
7.4 China Prophylactic Human Vaccine Consumption (2017-2022)
-
7.5 Japan Prophylactic Human Vaccine Consumption (2017-2022)
-
7.6 India Prophylactic Human Vaccine Consumption (2017-2022)
-
7.7 South Korea Prophylactic Human Vaccine Consumption (2017-2022)
8 Region and Country-wise Prophylactic Human Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.4 China Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.6 India Prophylactic Human Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Prophylactic Human Vaccine Consumption Forecast (2022-2028)
9 Global Prophylactic Human Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Prophylactic Human Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Prophylactic Human Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Prophylactic Human Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Prophylactic Human Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prophylactic Human Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Prophylactic Human Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prophylactic Human Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prophylactic Human Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prophylactic Human Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prophylactic Human Vaccine Market Competitive Analysis
-
14.1 Zoetis
-
14.1.1 Zoetis Company Details
-
14.1.2 Zoetis Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Zoetis Prophylactic Human Vaccine Product and Service
-
14.2 GSK
-
14.2.1 GSK Company Details
-
14.2.2 GSK Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GSK Prophylactic Human Vaccine Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Prophylactic Human Vaccine Product and Service
-
14.4 McKesson Medical
-
14.4.1 McKesson Medical Company Details
-
14.4.2 McKesson Medical Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 McKesson Medical Prophylactic Human Vaccine Product and Service
-
14.5 Biovac
-
14.5.1 Biovac Company Details
-
14.5.2 Biovac Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biovac Prophylactic Human Vaccine Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Prophylactic Human Vaccine Product and Service
-
14.7 Merial
-
14.7.1 Merial Company Details
-
14.7.2 Merial Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merial Prophylactic Human Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prophylactic Human Vaccine
-
Figure Prophylactic Human Vaccine Picture
-
Table Global Prophylactic Human Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prophylactic Human Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prophylactic Human Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prophylactic Human Vaccine Consumption by Country (2017-2022)
-
Figure United States Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prophylactic Human Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Prophylactic Human Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prophylactic Human Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Scientific Research Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prophylactic Human Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prophylactic Human Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Zoetis (Foundation Year, Company Profile and etc.)
-
Table Zoetis Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zoetis Prophylactic Human Vaccine Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Prophylactic Human Vaccine Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Prophylactic Human Vaccine Product and Service
-
Table McKesson Medical (Foundation Year, Company Profile and etc.)
-
Table McKesson Medical Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table McKesson Medical Prophylactic Human Vaccine Product and Service
-
Table Biovac (Foundation Year, Company Profile and etc.)
-
Table Biovac Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biovac Prophylactic Human Vaccine Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Prophylactic Human Vaccine Product and Service
-
Table Merial (Foundation Year, Company Profile and etc.)
-
Table Merial Prophylactic Human Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merial Prophylactic Human Vaccine Product and Service
-
